Profile
| Metric | Value |
|---|---|
| Full Name | Centene Corporation |
| Ticker | NYSE: CNC |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Country | United States |
| IPO | |
| Indexes | |
| Website | centene.com |
| Employees | 60,500 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $41.78 | |
| Price, 1D Change | +1.53% | |
| Market Cap | $21B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.16 | |
| Revenue | $163B | |
| Revenue, 1Y Change | +5.89% | |
| EPS | $6.31 | |
| EPS, 1Y Change | +27.44% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | CNTE | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $6.31 | |
| EPS Estimate | $2.03 | |
| EPS Est. Change | -67.79% | |
| Revenue | $163.07B | |
| Revenue Estimate | $192.88B | |
| Revenue Est. Change | +18.28% | |
| Current Price | $41.78 | |
| Price Target | - | $38.00 |
| Price Tgt. Change | - | -9.05% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $6.68 | $4.95 | -25.88% | |
| $6.84 | $6.31 | -7.70% | |
| $2.03 | N/A | -67.79% | |
| $2.89 | N/A | -54.17% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $150.55B | $154.00B | +2.29% | |
| $161.24B | $163.07B | +1.14% | |
| $192.88B | N/A | +18.28% | |
| $193.17B | N/A | +18.45% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -30.95% | |
| Price, 3Y | -49.05% | |
| Market Cap, 1Y | -31.56% | |
| Market Cap, 3Y | -54.53% | |
| Revenue, 1Y | +5.89% | |
| Revenue, 3Y | +29.44% | |
| EPS, 1Y | +27.44% | |
| EPS, 3Y | +176.63% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $41.78 | |
| SMA 200 | $42.72 | |
| SMA 200 vs Price | +2.25% | |
| SMA 50 | $37.74 | |
| SMA 50 vs Price | -9.67% | |
| Beta | 0.16 | |
| ATR | $1.19 | |
| 14-Day RSI | 66.15 | |
| 10-Day Volatility | 15.90% | |
| 1-Year Volatility | 58.67% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $163.07B | |
| EPS | $6.31 | |
| Gross Profit | $0.00 | |
| Gross Margin | 0.00% | |
| Operating Profit | $3.28B | |
| Operating Margin | 2.01% | |
| Net Income | $3.29B | |
| Net Margin | 2.02% | |
| EBITDA | $6.20B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.74 | |
| Current Ratio | 1.11 | |
| - | ||
| - | ||
| F-Score | 4 | |
| Altman Z-Score | 2.65 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 0.11 | |
| PB Ratio | 0.98 | |
| EV/EBITDA | -6.87 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $26.41B | |
| Cash & Equivalents | $14.06B | |
| Total Assets | $83.58B | |
| Current Assets | $38.00B | |
| Total Liabilities | $57.07B | |
| Current Liabilities | $34.26B | |
| Total Debt | $19.43B | |
| Short Term Debt | $268.00M | |
| Accounts Payable | $15.18B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $159.77B | |
| Operating Expenses | -$3.28B | |
| Cost Of Goods Sold | $146.24B | |
| SG&A | $0.00 | |
| D&A | $1.24B | |
| Interest Expense | $0.00 | |
| Income Tax | $963.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $154.00M | |
| CFI | -$1.05B | |
| CFF | -$2.41B | |
| Capex | $644.00M | |
| Free Cash Flow | -$490.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Bernstein | → | |
| Wells Fargo | → | |
| JP Morgan | → | |
| Barclays | → | |
| TD Cowen | → | |
| Goldman Sachs | → | |
| UBS | → | |
| Truist Securities | → | |
| Cantor Fitzgerald | → | |
| Morgan Stanley | → |
Analyst sentiment
Institutional ownership
Screeners with CNC
Data Sources & References
- CNC Official Website www.centene.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1071739/000107173925000183/0001071739-25-000183-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1071739/000107173925000027/0001071739-25-000027-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- CNC Profile on Yahoo Finance finance.yahoo.com/quote/CNC
- CNC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cnc
FAQ
What is the ticker symbol for Centene Corporation?
The ticker symbol for Centene Corporation is NYSE:CNC
Does Centene Corporation pay dividends?
No, Centene Corporation does not pay dividends
What sector is Centene Corporation in?
Centene Corporation is in the Healthcare sector
What industry is Centene Corporation in?
Centene Corporation is in the Healthcare Plans industry
What country is Centene Corporation based in?
Centene Corporation is headquartered in United States
When did Centene Corporation go public?
Centene Corporation initial public offering (IPO) was on December 13, 2001
Is Centene Corporation in the S&P 500?
Yes, Centene Corporation is included in the S&P 500 index
Is Centene Corporation in the NASDAQ 100?
No, Centene Corporation is not included in the NASDAQ 100 index
Is Centene Corporation in the Dow Jones?
No, Centene Corporation is not included in the Dow Jones index
When was Centene Corporation last earnings report?
Centene Corporation's most recent earnings report was on October 29, 2025
When does Centene Corporation report earnings?
The next expected earnings date for Centene Corporation is February 6, 2026